Pretreatment vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC)
Saved in:
| Title: | Pretreatment vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC) |
|---|---|
| Authors: | Laack, Eckart1 laack@uke.uni-hamburg.de, Scheffler, Antje1, Burkholder, Iris2, Boeters, Ina1, Andritzky, Birte1, Schuch, Gunter1, Görn, Michael1, Vohwinkel, Gaby1, Edler, Lutz2, Fiedler, Walter1, Hossfeld, Dieter Kurt1 |
| Source: | Lung Cancer (01695002). Oct2005, Vol. 50 Issue 1, p51-58. 8p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
